Corentec Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
28,263
26,583
30,347
35,974
37,849
Cost of Goods Sold (COGS) incl. D&A
15,711
14,197
14,934
17,512
19,576
Gross Income
12,552
12,386
15,413
18,462
18,273
SG&A Expense
10,903
12,571
14,426
16,974
18,865
EBIT
1,624
198
972
-
652
Unusual Expense
741
271
492
1,229
6,706
Non Operating Income/Expense
363
7
191
589
959
Interest Expense
718
732
713
581
1,026
Pretax Income
113
1,024
141
243
9,519
Income Tax
3,235
327
584
224
2,140
Equity in Affiliates
-
115
417
-
-
Consolidated Net Income
3,348
1,466
859
466
7,379
Net Income
3,348
1,466
859
466
7,379
Net Income After Extraordinaries
3,348
1,465
859
466
7,379
Net Income Available to Common
3,348
1,467
859
466
7,379
EPS (Basic)
419.00
178.00
97.00
52.00
747.00
Basic Shares Outstanding
8
8
9
9
10
EPS (Diluted)
418.76
177.76
96.66
52.43
747.10
Diluted Shares Outstanding
8
8
9
9
10
EBITDA
4,484
3,108
5,013
6,013
5,527
Other Operating Expense
25
14
14
38
60
Non-Operating Interest Income
311
185
182
85
234
Equity in Affiliates (Pretax)
-
-
-
72
410

About Corentec Co.

View Profile
Address
12 Yeongsanhong 1-gil
Cheonan SC 31056
Korea, Republic Of
Employees -
Website http://www.corentec.com
Updated 09/14/2018
Corentec Co., Ltd. engages in the manufacture of medical instruments. Its product line are Bencox, Lospa, and Lospa IS. Bencox offers acetabular system and femoral components.